How have XOMAP shares performed in 2024?

XOMA's stock was trading at $25.41 at the beginning of the year. Since then, XOMAP stock has decreased by 2.1% and is now trading at $24.87. View the best growth stocks for 2024 here .

Are investors shorting XOMA?

XOMA saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 2,700 shares, an increase of 50.0% from the March 15th total of 1,800 shares. Based on an average trading volume of 1,400 shares, the days-to-cover ratio is presently 1.9 days. View XOMA's Short Interest .

How often does XOMA pay dividends? What is the dividend yield for XOMA?

XOMA declared a quarterly dividend on Wednesday, February 21st. Stockholders of record on Wednesday, April 3rd will be given a dividend of $0.5391 per share on Monday, April 15th. This represents a $2.16 dividend on an annualized basis and a yield of 8.67%. The ex-dividend date of this dividend is Tuesday, April 2nd. Read our dividend analysis for XOMAP .

Is XOMA a good dividend stock?

XOMA (NASDAQ:XOMAP) pays an annual dividend of $2.16 per share and currently has a dividend yield of 9.29%. XOMAP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for XOMAP .

How do I buy shares of XOMA?

Shares of XOMAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:XOMAP

XOMA (XOMAP) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free XOMAP Stock Alerts

$24.87

-0.12 (-0.48%)

(As of 04/19/2024 ET)

Compare

Today's Range: $24.87
▼
$25.09
50-Day Range: $24.66
▼
$25.43
52-Week Range: $21.40
▼
$25.98

Volume: 864 shs
Average Volume: 1,819 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: 8.69%
Price Target: N/A

Stock Analysis Chart Competitors Dividend Financials Headlines SEC Filings Short Interest Social Media

Get XOMA alerts:

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About XOMA Stock (NASDAQ:XOMAP)

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

XOMAP Stock Price History

30 days | 90 days | 365 days | Advanced Chart

XOMAP Stock News Headlines

April 17, 2024 | thestreet.com

XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

April 12, 2024 | americanbankingnews.com

XOMA Co. (NASDAQ:XOMAP) Sees Significant Growth in Short Interest

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

March 21, 2024 | msn.com

XOMA Corp - 8.375% DP PFD B declares $0.5234 dividend

March 13, 2024 | finanznachrichten.de

Adhoc: Kuros Biosciences AG: Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023

March 11, 2024 | markets.businessinsider.com

Analysts Conflicted on These Healthcare Names: Xoma (XOMA) and Lexicon Pharmaceuticals (LXRX)

February 23, 2024 | msn.com

Cox Communications wins order overturning $1 billion US copyright verdict

February 17, 2024 | finance.yahoo.com

XOMA Jun 2024 20.000 put

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

February 17, 2024 | finance.yahoo.com

XOMA Sep 2024 12.500 put

February 16, 2024 | markets.businessinsider.com

Strategic Acquisitions and Royalty Income Streams Justify Buy Rating for Xoma

February 16, 2024 | marketwatch.com

Kinnate Biopharma Shares Rise on XOMA Acquisition

February 16, 2024 | markets.businessinsider.com

Kinnate Biopharma To Be Acquired By XOMA In Cash Deal; Stock Gains

January 18, 2024 | finanznachrichten.de

XOMA Corporation: XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA Acquisition

January 18, 2024 | finance.yahoo.com

XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition

January 18, 2024 | finance.yahoo.com

XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition

January 8, 2024 | marketwatch.com

XOMA Names Hughes Permanent CEO; Wyszomierski Becomes Chairman

January 8, 2024 | finance.yahoo.com

XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of Directors

December 22, 2023 | benzinga.com

XOMA Stock (NASDAQ:XOMA) Dividends: History, Yield and Dates

November 11, 2023 | morningstar.com

XOMA Corp XOMA

November 7, 2023 | msn.com

XOMA GAAP EPS of -$0.60 misses by $0.12, revenue of $0.83M misses by $0.36M

October 27, 2023 | finanznachrichten.de

ObsEva SA: Organon Returns Ebopiprant to XOMA

October 27, 2023 | finance.yahoo.com

Organon Returns Ebopiprant to XOMA

September 18, 2023 | msn.com

Xoma (XOMA) Moves 7.7% Higher: Will This Strength Last?

September 15, 2023 | money.usnews.com

XOMA Corp

September 13, 2023 | markets.businessinsider.com

H.C. Wainwright Sticks to Their Buy Rating for Xoma (XOMA)

August 13, 2023 | finance.yahoo.com

Owning 35% shares,institutional owners seem interested in XOMA Corporation (NASDAQ:XOMA),

See More Headlines

Receive XOMAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 4/15 Dividend: 4/02/2024
Dividend Payable: 4/15/2024
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:XOMAP
CUSIP: N/A
CIK: 791908
Web: www.xoma.com
Phone: 510-204-7200
Fax: N/A
Employees: 13
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $4.76 million
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Mr. Owen P. Hughes Jr. (Age 49)
CEO & Director
Comp: $193.75k
Mr. Thomas M. Burns (Age 50)
Senior VP of Finance & CFO
Comp: $759.24k
Mr. Brad Sitko (Age 43)
Chief Investment Officer
Comp: $867.08k

Key Competitors

View All Competitors

XOMAP Stock Analysis - Frequently Asked Questions

How have XOMAP shares performed in 2024?: XOMA's stock was trading at $25.41 at the beginning of the year. Since then, XOMAP stock has decreased by 2.1% and is now trading at $24.87.
View the best growth stocks for 2024 here.
Are investors shorting XOMA?: XOMA saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 2,700 shares, an increase of 50.0% from the March 15th total of 1,800 shares. Based on an average trading volume of 1,400 shares, the days-to-cover ratio is presently 1.9 days.
View XOMA's Short Interest.
How often does XOMA pay dividends? What is the dividend yield for XOMA?: XOMA declared a quarterly dividend on Wednesday, February 21st. Stockholders of record on Wednesday, April 3rd will be given a dividend of $0.5391 per share on Monday, April 15th. This represents a $2.16 dividend on an annualized basis and a yield of 8.67%. The ex-dividend date of this dividend is Tuesday, April 2nd.
Read our dividend analysis for XOMAP.

Is XOMA a good dividend stock?: XOMA (NASDAQ:XOMAP) pays an annual dividend of $2.16 per share and currently has a dividend yield of 9.29%. XOMAP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for XOMAP.
How do I buy shares of XOMA?: Shares of XOMAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:XOMAP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial